WAM
HAE icon

Wolverine Asset Management’s Haemonetics HAE Stock Holding History

Wolverine Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,200
Closed -$272K – 1910
2023
Q2 		$272K Hold
3,200
– – ﹤0.01% 952
2023
Q1 		$265K Buy
+3,200
New +$259K ﹤0.01% 988

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wolverine Asset Management's HAE Position: Q1 2026 in Review

Wolverine Asset Management opened a new position in Haemonetics (HAE) in Q1 2026: 671 shares worth $37.8K. The stake represents ﹤0.01% of the portfolio and ranks #1298 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in HAE as recently as Q3 2025.

Wolverine Asset Management first reported a position in HAE in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.43M in Q2 2024. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Wolverine Asset Management held 671 shares of Haemonetics worth $37.8K as of Q1 2026.
  • Haemonetics was a new Wolverine Asset Management position in Q1 2026.
  • Haemonetics made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1298 holding.
  • Wolverine Asset Management first reported a position in Haemonetics in Q2 2021 and has held it in 6 quarters since.
  • Wolverine Asset Management's Haemonetics position peaked at $1.43M in Q2 2024.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.